- Lab Tests
- Health Corner
ELIQUIS 5MG TABLET contains Apixaban, which belongs to the group of medicines called Anticoagulants. It is used to prevent blood clots in patients with an irregular heartbeat (atrial fibrillation). These blood clots can dislodge and travel throughout the body, resulting in systemic embolism and stroke.
ELIQUIS 5MG TABLET also helps in the treatment of blood clots in the legs (deep vein thrombosis) and the veins of the lungs (pulmonary embolism) and in the prevention of their recurrence in either legs or lungs.
ELIQUIS 5MG TABLET should be taken with caution in patients who have liver or kidney disease. ELIQUIS 5MG TABLET is contraindicated in patients who have active bleeding or have a disease that can lead to active bleeding, such as an active ulcer or a recent bleed in the brain.
ELIQUIS 5MG TABLET should be used with caution during pregnancy or breastfeeding. ELIQUIS 5MG TABLET is not recommended for use by children and adolescents (under the age of 18). ELIQUIS 5MG TABLET should be used with caution in elderly patients over the age of 80.
The most common side effects of taking ELIQUIS 5MG TABLET are bleeding (eyes, nose, gums, urine, rectum, stomach or bowel), bruising or swelling, anaemia, low blood pressure and a quickened heart rate. If any of these symptoms worsen, contact your doctor immediately.
ELIQUIS 5MG TABLET helps to prevent the formation of blood clots by acting on the blood clotting mechanism of the body. It blocks clotting factor Xa which is an essential factor in the clotting mechanism.
Take ELIQUIS 5MG TABLET as advised by your physician. Swallow the medicine with a glass of water. If you have difficulty swallowing the tablet as a whole, talk to your doctor about other ways to take ELIQUIS 5MG TABLET. Your doctor will decide the correct dose and duration for you depending on your age, body weight and disease condition.
Stop taking ELIQUIS 5MG TABLET and contact your doctor immediately if you experience any of the following side effects:
Take this medicine with or just after meals. Stick to simple meals. Avoid eating oily or spicy foods.
The effects of ELIQUIS 5MG TABLET on pregnancy and the unborn child are not known, hence it is not recommended to take it during pregnancy. Consult your doctor before taking it.
It is not known if ELIQUIS 5MG TABLET passes into human breast milk. Consult your doctor before taking this medicine while breastfeeding.
ELIQUIS 5MG TABLET does not impair the ability to drive or use machines. Consult your doctor.
ELIQUIS 5MG TABLET should be taken with caution in patients with severe kidney disease or who are on dialysis. Consult your doctor before taking it.
ELIQUIS 5MG TABLET is not recommended for use in patients having liver diseases such as hepatic coagulopathy. It should be used with caution in patients with liver problems or a history of liver problems. Consult your doctor before taking it.
Do not take ELIQUIS 5MG TABLET if you are allergic to Apixaban.
ELIQUIS 5MG TABLET should be taken with caution in patients with prosthetic heart valves. Consult your doctor before taking it.
Before taking ELIQUIS 5MG TABLET, inform your doctor if you:
Use in pediatrics:
Use in geriatrics:
A. Drug–Drug Interactions:
If you or anyone else accidentally take too much of ELIQUIS 5MG TABLET, consult your doctor immediately or visit the nearby hospital. Overdose of ELIQUIS 5MG TABLET can result in increased bleeding.
|Therapeutic Indication||:||Prevention of blood clots in atrial fibrillation, Deep vein thrombosis, Pulmonary embolism|
Is ELIQUIS 5MG TABLET a blood thinner?
Yes. [GBKEYWORD] is a blood thinner, also called an anticoagulant. It prevents blood clot formation and makes it easier for the blood to flow through the body. ELIQUIS 5MG TABLET blocks an essential factor of the clotting mechanism, thereby making it easy for the blood to flow.
What precautions should I take while taking ELIQUIS 5MG TABLET?
Patients taking ELIQUIS 5MG TABLET should inform their doctor about their pre-existing liver, heart or kidney disease. As ELIQUIS 5MG TABLET is an anti-coagulant and helps in the prevention of blood clot formation, it is important to tell your doctor about any bleeding disorder or any active condition that can cause a bleed. Consult your doctor before taking it.
What if I forget to take a dose of ELIQUIS 5MG TABLET?
Take the dose as soon as you remember, then take the next dose of ELIQUIS 5MG TABLET at the usual time and then continue as normal. Consult your doctor once.
Is ELIQUIS 5MG TABLET safe during pregnancy and breastfeeding?
No, ELIQUIS 5MG TABLET is not recommended for use during pregnancy and breastfeeding. If you are pregnant, breastfeeding or planning to have a baby, consult your doctor before taking ELIQUIS 5MG TABLET. If you become pregnant while taking ELIQUIS 5MG TABLET, contact your doctor immediately.
What is ELIQUIS 5MG TABLET used for?
ELIQUIS 5MG TABLET is used to prevent blood clots in patients with an irregular heartbeat (atrial fibrillation). These blood clots have the potential to dislodge and travel throughout the body, resulting in systemic embolism and stroke.ELIQUIS 5MG TABLET also helps in the treatment of blood clots in the legs (deep vein thrombosis) and the veins of the lungs (pulmonary embolism) and in the prevention of their recurrence in either legs or lungs.
What are the side effects of taking ELIQUIS 5MG TABLET?
The most common side effects of taking ELIQUIS 5MG TABLET are bleeding (eyes, nose, gums, urine, rectum, stomach or bowel), tiredness or paleness due to anaemia, low blood pressure and nausea. Consult your doctor if any of these symptoms get worse.
What foods should I avoid while taking ELIQUIS 5MG TABLET?
Avoid consuming grapefruits or juices as it impacts the effects of ELIQUIS 5MG TABLET, which may lead to bleeding. To prevent such complications, consult your doctor before taking ELIQUIS 5MG TABLET.
1. Joseph T. DiPiro, Robert L. Talbert, Cardiovascular Diseases, Pharmacotherapy: A Pathophysiologic Approach, Eighth Edition. 2011. Page – 324.
2. Joseph P. Broderick, Jordan B. Bonomo, Brett M. Kissela, Jane C. Khoury, Charles J. Moomaw, Kathleen Alwell, Daniel Woo, Matthew L. Flaherty, Pooja Khatri, Opeolu Adeoye, Simona Ferioli, Dawn O. Kleindorfer. Withdrawal of Antithrombotic Agents and Its Impact on Ischemic Stroke Occurrence. NIH. National Library of Medicine. National Center for Biotechnology Information. PubMed Central. June 2011. [Accessed on 20th April 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166233/
3. Catalent Anagni S.R.L. Electronic Medicines Compendium (EMC). [Revised in September 2021] [Accessed on 20th April 2022]. https://www.medicines.org.uk/emc/files/pil.2878.pdf
4. Bristol-Myers Squibb Company, Pfizer Inc. Bristol Myers Squib. [Revised in September 2021] [Accessed on 20th April 2022]. https://packageinserts.bms.com/pi/pi_eliquis.pdf
Written By Dr. Dhivakaran R, BDS
Last updated on 25 Nov 2022 | 03:08 PM(IST)
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.